AV
DGX icon

ASR Vermogensbeheer’s Quest Diagnostics DGX Stock Holding History

ASR Vermogensbeheer’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841K Sell
3,970
-4,321
-52% -$848K 0.01% 417
2026
Q1 		$1.62M Buy
8,291
+185
+2% +$35.9K 0.02% 381
2025
Q4 		$1.41M Sell
8,106
-91
-1% -$16.6K 0.02% 402
2025
Q3 		$1.56M Sell
8,197
-84
-1% -$14.9K 0.02% 385
2025
Q2 		$1.49M Sell
8,281
-43
-0.5% -$7.47K 0.02% 395
2025
Q1 		$1.41M Buy
+8,324
New +$1.37M 0.02% 381

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

ASR Vermogensbeheer's DGX Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Quest Diagnostics (DGX) stake by 52% in Q2 2026, selling an estimated $848K and leaving 3,970 shares worth $841K. The position accounts for 0.01% of the portfolio, ranked #417.

ASR Vermogensbeheer first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.62M in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • ASR Vermogensbeheer held 3,970 shares of Quest Diagnostics worth $841K as of Q2 2026.
  • ASR Vermogensbeheer sold 4,321 Quest Diagnostics shares in Q2 2026, an estimated $848K.
  • Quest Diagnostics made up 0.01% of ASR Vermogensbeheer's portfolio in Q2 2026, its #417 holding.
  • ASR Vermogensbeheer first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's Quest Diagnostics position peaked at $1.62M in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.